Orphan designation: Magrolimab Treatment of acute myeloid leukaemia, 11/11/2015 Withdrawn
Overview Please note that this product was withdrawn from the Union Register of orphan medicinal products in February 2025 on request of the Sponsor. On 11 November 2015, orphan designation (EU/3/15/1582) was granted by the European Commission …